| Sign In to gain access to subscriptions and/or personal tools. |
Characterization of a High-Throughput Screening Assay for Inhibitors of Elongation Factor P and Ribosomal Peptidyl Transferase ActivityBiology I, Pfizer, Kalamazoo, MI
Global Technology, Pfizer, Kalamazoo, MI
Biology I, Pfizer, Kalamazoo, MI, Micromyx, Kalamazoo, MI
Global Enzymology & Kinetics, Pfizer, Kalamazoo, MI
Global HTS, Pfizer, Kalamazoo, MI
Global HTS, Pfizer, Kalamazoo, MI, Novartis Pharma AG, Basel, Switzerland Elongation Factor P (EF-P) is an essential component of bacterial protein synthesis, enhancing the rate of translation by facilitating the addition of amino acids to the growing peptide chain. Using purified Staphylococcus aureus EF-P and a reconstituted Escherichia coli ribosomal system, an assay monitoring the addition of radiolabeled N-formyl methionine to biotinylated puromycin was developed. Reaction products were captured with streptavidin-coated scintillation proximity assay (SPA) beads and quantified by scintillation counting. Data from the assay were used to create a kinetic model of the reaction scheme. In this model, EF-P binding to the ribosome essentially doubled the rate of the ribosomal peptidyl transferase reaction. As described here, EF-P bound to the ribosomes with an apparent Ka of 0.75 µM, and the substrates N-fMet-tRNA and biotinylated puromycin had apparent Kms of 19 µM and 0.5 µM, respectively. The assay was shown to be sensitive to a number of antibiotics known to target ribosomal peptide bond synthesis, such as chloramphenicol and puromycin, but not inhibitors that target other stages of protein synthesis, such as fusidic acid or thiostrepton.
Key Words: protein synthesis • Elongation Factor P • high-throughput screening
This version was published on October
1, 2006 Journal of Biomolecular Screening, Vol. 11, No. 7,
736-742 (2006) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
